Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Progen Pharmaceuticals Ltd

+ Add to Watchlist

PGLA:US

0.1550 USD 0.0200 14.81%

As of 20:10:04 ET on 03/31/2015.

Snapshot for Progen Pharmaceuticals Ltd (PGLA)

Open: 0.1550 Day's Range: 0.1550 - 0.1550 Volume: 3,388
Previous Close: 0.1350 52wk Range: 0.1350 - 1.8600 1-Yr Rtn: -86.64%

Stock Chart for PGLA

No chart data available.
  • PGLA:US 0.1550
  • 1D
  • 1M
  • 1Y
0.1350
Interactive PGLA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PGLA

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 8.57
Shares Outstanding (M) 55.29
30 Day Average Volume 2,360
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/26/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PGLA

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for PGLA

Progen Pharmaceuticals Limited is involved in the discovery, research and development of potential biopharmaceutical therapeutics for the treatment of human diseases. The Company also provides contract services related to the process development, manufacture and quality assurance of biological products.

Indrajit Solomon Arulampalam "Jitto"ChairmanLeslie TillackCEO:Pharmasynth
Heng Hsin TangActing Managing DirectorLee HorobinGen Mgr:Finance
More Company Profile & Key Executives for PGLA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil